Schizophrenia: Research Leaders and Landscape

Top research leaders (by recent publication volume)

Ranked by recent publication volume; names not yet disambiguated and not citation-weighted. The full brief adds ORCID disambiguation, citation weighting, and clinical-trial investigator data.

Leading institutions

Princeton (9), Indiana University School of Medicine (7), University of California (6), Karuna Therapeutics (5), College of Pharmacy (3), Chiba University Center for Forensic Mental Health (2), The First Affiliated Hospital of Zhengzhou University (2), Renaissance School of Medicine at Stony Brook University (2), Uptown Research Institute (2), University of Miami Miller School of Medicine (2)

Active subtopics

Antipsychotic Agents (55), Schizophrenia (54), Thiadiazoles (25), Benzilates (22), Pyridines (22), Muscarinic Agonists (21), Nortropanes (21), Drug Combinations (16)

Top journals

Schizophrenia research (6), The Journal of clinical psychiatry (5), Journal of psychopharmacology (Oxford, England) (4), BMC psychiatry (3), Psychiatry research (2), Schizophrenia bulletin open (2)

Representative recent papers

Xanomeline-Trospium Validates Muscarinic Agonism as an Effective Non-Dopaminergic Treatment for Schizophrenia. (2026) · PMID 42450007

Effects of xanomeline-trospium on the gut-lung microbiota axis and susceptibility to LPS-induced acute lung injury in male and fem (2026) · PMID 42400654

Post-marketing safety surveillance of the novel muscarinic antipsychotic Xanomeline-Trospium for schizophrenia: A comparative disp (2026) · PMID 42288069

A Qualitative Investigation of the Experience of Taking Xanomeline and Trospium Chloride for Schizophrenia, Part 2: Perceived Chan (2026) · PMID 42170669

Advances in schizophrenia research and treatment: exploring neurotransmitter imbalances, genetics, and innovative therapies. (2026) · PMID 42162691